AMAG Pharmaceuticals Provides Financial and Business Update

Go back to AMAG Pharmaceuticals Provides Financial and Business Update

Janney Montgomery Scott Downgrades AMAG Pharmaceuticals (AMAG) to Neutral

January 10, 2017 8:28 AM EST

Janney Montgomery Scott downgraded AMAG Pharmaceuticals (NASDAQ: AMAG) from Buy to Neutral.

For an analyst ratings summary and ratings history on AMAG Pharmaceuticals click here. For more ratings news on AMAG Pharmaceuticals click here.

Shares of AMAG Pharmaceuticals closed at $23.00 yesterday.

... More

Leerink Partners Downgrades AMAG Pharmaceuticals (AMAG) to Market Perform

January 10, 2017 8:14 AM EST

Leerink Partners downgraded AMAG Pharmaceuticals (NASDAQ: AMAG) from Outperform to Market Perform with a price target of $25.00 (from $39.00).

For an analyst ratings summary and ratings history on AMAG Pharmaceuticals click here. For more ratings news on AMAG Pharmaceuticals click here.

Shares of AMAG Pharmaceuticals closed at $23.00 yesterday.

... More

Raymond James Downgrades AMAG Pharmaceuticals (AMAG) to Underperform

January 9, 2017 10:32 AM EST

Raymond James downgraded AMAG Pharmaceuticals (NASDAQ: AMAG) from Market Perform to Underperform.

For an analyst ratings summary and ratings history on AMAG Pharmaceuticals click here. For more ratings news on AMAG Pharmaceuticals click here.

Shares of AMAG Pharmaceuticals closed at $35.70 yesterday.

... More